Post COVID-19 and NeurOptimal® Study Participant Intake Questionnaire
In what ways does NeurOptimal® improve the general well-being of participants who have had COVID-19?
We are an international group of NeurOptimal® Dynamical® Neurofeedback Trainers who are passionate about what we do and have a desire to understand how NeurOptimal® may help individuals who are impacted by persistent Post-Acute Covid-19 concerns.
This study will be conducted over a period of 12 months. Individuals may enroll at any time, but no later than November 19, 2021.
All qualified participants will complete 20 NeurOptimal® neurofeedback sessions as a part of the study. The group will be reporting the severity of their Post-Acute COVID-19 concerns after each neurofeedback session. Before proceeding, all information about this study should be reviewed and understood. Please visit
to access pertinent research information.
NeurOptimal® is considered a general wellness tool. NeurOptimal® is not used for diagnosis or treatment of any medical condition of any kind nor will it cure any medical condition.
Sign in to Google
to save your progress.
INFORMED CONSENT: You are making a decision to participate in a research study. Select the boxes below to confirm that you have read the Study Description found at
, and that you voluntarily agree to participate in the study.
I have read the Study Description at
Yes, I voluntarily agree to participate in this study.
Today's date MM/DD/YYYY
Page 1 of 6
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google.
Terms of Service